Table 3.
Comparison between MMR-d NR and MMR-d NI/NP CRC patients
| MMR-d NR (N=18) | MMR-d NI/NP (N=68) | P value | |
|---|---|---|---|
| Age (yars) | 77.28±12.61 | 67.18±15.23 | 0.0114 |
| Sex | 0.0225 | ||
| Female | 16 (88.89%) | 41 (60.29%) | |
| Male | 2 (11.11%) | 27 (39.71%) | |
| Histological grade | 0.0385 | ||
| Low | 8 (44.44%) | 48 (70.59%) | |
| High | 10 (55.56%) | 20 (29.41%) | |
| Tumour location | 0.2495 | ||
| Left | 2 (11.11%) | 16 (23.53%) | |
| Right | 16 (88.89%) | 52 (76.47%) | |
| TNM stage | 0.8796 | ||
| I-II | 14 (77.78%) | 54 (79.41%) | |
| III-IV | 4 (22.22%) | 14 (20.59%) |
CRC, colorectal carcinoma; MMR, mismatch repair; MMR-d, MMR-deficiency; MMR-p, MMR-proficiency; NI, neutrophil-intermediate; NP, neutrophil-poor; NR, neutrophil-rich; TNM, tumour, node, metastasis.